Experience
Vifor (International) AG and American Regent, Inc. v. Mylan Labs. Ltd. et al.
Vifor (International) AG and American Regent, Inc.
Mylan Labs. Ltd. et al.
Represented Vifor and American Regent in two Hatch-Waxman Act cases against Mylan and Sandoz regarding their attempts to obtain FDA approval for their respective ANDAs directed to generic copies of Injectafer®. After a six-day bench trial, the cases resulted in a favorable settlement for our clients with a generic entry date well past the expiration of the composition patents.
Vifor (International) AG and American Regent, Inc. v. Mylan Labs. Ltd. et al., 3:19-cv-13955, 3:19-cv-16305, D.N.J., Judges Wolfson, Arpert
Related Professionals
- C. Collette Corser
- Associate
- Washington, DC
- +1 202 408 6052
- Kathryn R. Judson
- Associate
- Atlanta, GA
- +1 404 653 6466
